Literature DB >> 31336534

DKA cases over the last three years: has anything changed?

T Stratigou1, N Vallianou2, B Vlassopoulou1, M Tzanela1, D Vassiliadi1, G Ioannidis1, S Tsagarakis1.   

Abstract

BACKGROUND: Diabetic ketoacidosis (DKA) has been related mainly to type 1 diabetes mellitus (T1DM). However, it is not solely related to T1DM. The purpose of this study was to assess the prevalence of DKA among type 1 and type 2 patients with diabetes mellitus, who were hospitalized in our Clinic due to DKA, as well as to determine the etiology beyond DKA. PATIENTS AND METHODS: A cohort of 109 patients with DKA, 17-86 years of age, who were hospitalized in the Department of Endocrinology, Diabetes and Metabolism of our hospital between 2015 and 2017, were included in the study.
RESULTS: Among the 109 patients, 50 (45.9%) had mild DKA, 48 (44.1%) had moderate DKA, whereas 11 patients (10%) had severe DKA. Sixty-five patients (60%) developed DKA as the first manifestation of T1DM, 30 patients (27%) developed DKA in the context of type 2 diabetes (T2DM), mainly due to the co-existence of serious infections, 11 patients (10%) had T1DM, but had omitted their insulin dosages, and 3 patients (3%) developed DKA due to unknown reasons.
CONCLUSIONS: Most patients with DKA presented with mild and moderate DKA and only a minority presented with the severe form of the disease. The etiology of DKA was mainly T1DM and less frequent uncontrolled T2DM, usually due to the co-existence of severe infections, while only in a tiny minority, the causes remained unidentifiable.
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic ketoacidosis; Infections; Type 1 and type 2 diabetes mellitus

Year:  2019        PMID: 31336534     DOI: 10.1016/j.dsx.2019.03.022

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  3 in total

1.  Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations.

Authors:  Nadine E Palermo; Archana R Sadhu; Marie E McDonnell
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

2.  Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors.

Authors:  Rebecca J Vitale; Yannis K Valtis; Marie E McDonnell; Nadine E Palermo; Naomi D L Fisher
Journal:  AACE Clin Case Rep       Date:  2020-12-28

3.  Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users.

Authors:  Monica Flores; Maryam Amir; Ramsha Ahmed; Suleiman Alashi; Manshi Li; Xiaofeng Wang; M Cecilia Lansang; Mohammed J Al-Jaghbeer
Journal:  BMJ Open Diabetes Res Care       Date:  2020-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.